Ragosa Mark, CFO of Kiniksa Pharmaceuticals ($KNSA), sold nearly $9.9 million in company shares across 16 open market transactions in the past year. His latest sale occurred on March 9, 2026. These sales rank 1,132nd among 11,678 insiders, surpassing the average of $8.6 million per seller and 6.4 transactions. No open market purchases were recorded.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1750 | $0.00 | 1,750.0000 | 78,979,030 | 50.00% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 5187 | $0.00 | 17,273.0000 | 78,979,030 | 42.92% | 0.01% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 2510 | $48.13 | 14,763.0000 | 78,979,030 | 14.53% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Share Option | 31150 | $0.00 | 31,150.0000 | 78,979,030 | 9999.99% | 0.04% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 7800 | $0.00 | 7,800.0000 | 78,979,030 | 9999.99% | 0.01% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Performance Share Unit | 15600 | $0.00 | 15,600.0000 | 78,979,030 | 9999.99% | 0.02% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1846 | $0.00 | 5,536.0000 | 78,979,030 | 25.01% | 0.00% |
| April 1, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1591 | $0.00 | 3,182.0000 | 78,979,030 | 33.33% | 0.00% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 2036 | $22.89 | 14,122.0000 | 78,979,030 | 16.85% | 0.00% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 10513 | $17.76 | 24,635.0000 | 78,979,030 | 74.44% | 0.01% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 13813 | $18.06 | 38,448.0000 | 78,979,030 | 56.07% | 0.02% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 10360 | $26.74 | 48,808.0000 | 78,979,030 | 26.95% | 0.01% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 17981 | $45.58 | 30,827.0000 | 78,979,030 | 36.84% | 0.02% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 18741 | $46.24 | 12,086.0000 | 78,979,030 | 60.79% | 0.02% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 2036 | $0.00 | 0.0000 | 78,979,030 | 100.00% | 0.00% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 10513 | $0.00 | 18,396.0000 | 78,979,030 | 36.37% | 0.01% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 13813 | $0.00 | 19,337.0000 | 78,979,030 | 41.67% | 0.02% |
| March 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 10360 | $0.00 | 22,790.0000 | 78,979,030 | 31.25% | 0.01% |
| Feb. 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 9114 | $42.85 | 20,817.0000 | 78,979,030 | 30.45% | 0.01% |
| Feb. 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 8374 | $12.97 | 27,460.0000 | 78,979,030 | 43.88% | 0.01% |
| Feb. 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 2471 | $16.90 | 29,931.0000 | 78,979,030 | 9.00% | 0.00% |
| Feb. 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 2471 | $0.00 | 0.0000 | 78,979,030 | 100.00% | 0.00% |
| Feb. 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 8731 | $43.72 | 12,086.0000 | 78,979,030 | 41.94% | 0.01% |
| Feb. 9, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 8374 | $0.00 | 0.0000 | 78,979,030 | 100.00% | 0.01% |
| Jan. 8, 2026 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 12000 | $41.89 | 19,086.0000 | 78,979,030 | 38.60% | 0.02% |
| Dec. 8, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 10512 | $10.76 | 73,927.0000 | 80,035,400 | 16.58% | 0.01% |
| Dec. 8, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 10512 | $0.00 | 14,016.0000 | 80,035,400 | 42.86% | 0.01% |
| Dec. 8, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 16165 | $0.00 | 12,123.0000 | 80,035,400 | 57.14% | 0.02% |
| Dec. 8, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 16164 | $0.00 | 5,388.0000 | 80,035,400 | 75.00% | 0.02% |
| Dec. 8, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 42841 | $41.49 | 31,086.0000 | 80,035,400 | 57.95% | 0.05% |
| Dec. 8, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 16165 | $11.97 | 63,415.0000 | 80,035,400 | 34.21% | 0.02% |
| Dec. 8, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 16164 | $11.10 | 47,250.0000 | 80,035,400 | 52.00% | 0.02% |
| Nov. 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 19900 | $40.94 | 31,086.0000 | 80,035,400 | 39.03% | 0.02% |
| Nov. 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 19900 | $30.93 | 50,986.0000 | 80,035,400 | 64.02% | 0.02% |
| Nov. 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 19900 | $0.00 | 0.0000 | 80,035,400 | 100.00% | 0.02% |
| Oct. 28, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 100 | $30.93 | 31,186.0000 | 80,035,400 | 0.32% | 0.00% |
| Oct. 28, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 100 | $41.00 | 31,086.0000 | 80,035,400 | 0.32% | 0.00% |
| Oct. 28, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 100 | $0.00 | 19,900.0000 | 80,035,400 | 0.50% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 2694 | $0.00 | 33,045.0000 | 77,942,082 | 8.88% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 2920 | $33.49 | 30,125.0000 | 77,942,082 | 8.84% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 1861 | $0.00 | 31,986.0000 | 77,942,082 | 6.18% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 900 | $34.28 | 31,086.0000 | 77,942,082 | 2.81% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 12275 | $0.00 | 12,275.0000 | 77,942,082 | 9999.99% | 0.02% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Share Option | 39363 | $0.00 | 39,363.0000 | 77,942,082 | 9999.99% | 0.05% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1592 | $0.00 | 4,773.0000 | 77,942,082 | 25.01% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1750 | $0.00 | 3,500.0000 | 77,942,082 | 33.33% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 2694 | $0.00 | 2,694.0000 | 77,942,082 | 50.00% | 0.00% |
| Sept. 2, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1861 | $0.00 | 0.0000 | 77,942,082 | 100.00% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 1592 | $0.00 | 28,601.0000 | 77,942,082 | 5.89% | 0.00% |
| Sept. 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 1750 | $0.00 | 30,351.0000 | 77,942,082 | 6.12% | 0.00% |
| Aug. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 18889 | $0.00 | 2,036.0000 | 77,942,082 | 90.27% | 0.02% |
| Aug. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 18889 | $32.89 | 27,009.0000 | 77,942,082 | 41.15% | 0.02% |
| Aug. 4, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 18889 | $22.89 | 45,898.0000 | 77,942,082 | 69.94% | 0.02% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 18299 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.02% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 18299 | $18.00 | 45,308.0000 | 76,145,617 | 67.75% | 0.02% |
| June 3, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 18299 | $28.80 | 27,009.0000 | 76,145,617 | 40.39% | 0.02% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Performance Share Option | 7368 | $0.00 | 7,368.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Performance Share Unit | 4558 | $0.00 | 4,558.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Performance Share Option | 7606 | $0.00 | 7,606.0000 | 76,145,617 | 9999.99% | 0.01% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Performance Share Unit | 4786 | $0.00 | 4,876.0000 | 76,145,617 | 5317.78% | 0.01% |
| April 30, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 21254 | $0.00 | 2,471.0000 | 76,145,617 | 89.58% | 0.03% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 20000 | $15.52 | 47,009.0000 | 76,145,617 | 74.05% | 0.03% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 22000 | $15.50 | 69,009.0000 | 76,145,617 | 46.80% | 0.03% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 42000 | $25.61 | 27,009.0000 | 76,145,617 | 60.86% | 0.06% |
| April 30, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 21254 | $16.90 | 48,263.0000 | 76,145,617 | 78.69% | 0.03% |
| April 30, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 21254 | $26.95 | 27,009.0000 | 76,145,617 | 44.04% | 0.03% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 12000 | $17.92 | 39,009.0000 | 76,145,617 | 44.43% | 0.02% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 13141 | $17.76 | 52,150.0000 | 76,145,617 | 33.69% | 0.02% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 25141 | $27.80 | 27,009.0000 | 76,145,617 | 48.21% | 0.03% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 20000 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.03% |
| April 29, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 22000 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.03% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 12000 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.02% |
| May 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 13141 | $0.00 | 28,909.0000 | 76,145,617 | 31.25% | 0.02% |
| April 26, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 990 | $0.00 | 0.0000 | 76,145,617 | 100.00% | 0.00% |
| April 26, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 990 | $0.00 | 27,488.0000 | 76,145,617 | 3.74% | 0.00% |
| April 26, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 479 | $21.37 | 27,009.0000 | 76,145,617 | 1.74% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 2694 | $0.00 | 2,694.0000 | 76,145,617 | 50.00% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 1303 | $20.28 | 26,498.0000 | 76,145,617 | 4.69% | 0.00% |
| April 7, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 2694 | $0.00 | 27,801.0000 | 76,145,617 | 10.73% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1750 | $0.00 | 3,500.0000 | 76,145,617 | 33.33% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 7382 | $0.00 | 7,382.0000 | 76,145,617 | 9999.99% | 0.01% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Performance Share Unit | 14765 | $0.00 | 14,765.0000 | 76,145,617 | 9999.99% | 0.02% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1592 | $0.00 | 4,773.0000 | 76,145,617 | 25.01% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 1750 | $0.00 | 25,132.0000 | 76,145,617 | 7.48% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 1592 | $0.00 | 26,724.0000 | 76,145,617 | 6.33% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 847 | $21.77 | 25,877.0000 | 76,145,617 | 3.17% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 770 | $21.77 | 25,107.0000 | 76,145,617 | 2.98% | 0.00% |
| April 1, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Share Option | 29480 | $0.00 | 29,480.0000 | 76,145,617 | 9999.99% | 0.04% |
| March 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 15944 | $0.00 | 8,374.0000 | 71,424,159 | 65.56% | 0.02% |
| March 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 15944 | $23.11 | 23,382.0000 | 71,424,159 | 40.54% | 0.02% |
| March 20, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 15944 | $12.97 | 39,326.0000 | 71,424,159 | 68.19% | 0.02% |
| March 19, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 8879 | $23.10 | 23,382.0000 | 71,424,159 | 27.52% | 0.01% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 872 | $0.00 | 0.0000 | 71,424,159 | 100.00% | 0.00% |
| March 17, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 11464 | $0.00 | 33,197.0000 | 71,424,159 | 25.67% | 0.02% |
| March 19, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 8879 | $0.00 | 24,318.0000 | 71,424,159 | 26.75% | 0.01% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 872 | $0.00 | 23,830.0000 | 71,424,159 | 3.80% | 0.00% |
| March 16, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 448 | $22.61 | 23,382.0000 | 71,424,159 | 1.88% | 0.00% |
| March 17, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 11464 | $12.97 | 34,846.0000 | 71,424,159 | 49.03% | 0.02% |
| March 17, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 11464 | $23.10 | 23,382.0000 | 71,424,159 | 32.90% | 0.02% |
| March 19, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 8879 | $12.97 | 32,261.0000 | 71,424,159 | 37.97% | 0.01% |
| March 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 36372 | $0.00 | 28,288.0000 | 71,424,159 | 56.25% | 0.05% |
| March 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 36372 | $11.97 | 59,330.0000 | 71,424,159 | 158.43% | 0.05% |
| March 12, 2025 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 36372 | $22.25 | 22,958.0000 | 71,424,159 | 61.30% | 0.05% |
| Dec. 9, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 18860 | $0.00 | 21,552.0000 | 71,726,685 | 46.67% | 0.03% |
| Dec. 6, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 2406 | $0.00 | 24,528.0000 | 71,726,685 | 8.93% | 0.00% |
| Dec. 9, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 18860 | $21.38 | 22,958.0000 | 71,726,685 | 45.10% | 0.03% |
| Dec. 9, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 18860 | $11.10 | 41,818.0000 | 71,726,685 | 82.15% | 0.03% |
| Dec. 6, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 8969 | $21.27 | 22,958.0000 | 71,726,685 | 28.09% | 0.01% |
| Dec. 6, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 2406 | $10.76 | 25,364.0000 | 71,726,685 | 10.48% | 0.00% |
| Dec. 5, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 1123 | $0.00 | 26,934.0000 | 71,726,685 | 4.00% | 0.00% |
| Dec. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 8969 | $0.00 | 33,081.0000 | 71,726,685 | 21.33% | 0.01% |
| Dec. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 5024 | $0.00 | 28,057.0000 | 71,726,685 | 15.19% | 0.01% |
| Dec. 5, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 1123 | $21.25 | 22,958.0000 | 71,726,685 | 4.66% | 0.00% |
| Dec. 5, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 1123 | $10.76 | 24,081.0000 | 71,726,685 | 4.89% | 0.00% |
| Dec. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 5024 | $21.25 | 22,958.0000 | 71,726,685 | 17.95% | 0.01% |
| Dec. 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 5024 | $10.76 | 27,982.0000 | 71,726,685 | 21.88% | 0.01% |
| Dec. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 8969 | $21.45 | 22,958.0000 | 71,726,685 | 28.09% | 0.01% |
| Dec. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 8969 | $10.76 | 31,927.0000 | 71,726,685 | 39.07% | 0.01% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Share Option | 33150 | $0.00 | 33,150.0000 | 71,004,640 | 9999.99% | 0.05% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 2694 | $0.00 | 5,388.0000 | 71,004,640 | 33.33% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1750 | $0.00 | 5,250.0000 | 71,004,640 | 25.00% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1861 | $0.00 | 1,861.0000 | 71,004,640 | 50.00% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 6365 | $0.00 | 6,365.0000 | 71,004,640 | 9999.99% | 0.01% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 956 | $26.74 | 22,958.0000 | 71,004,640 | 4.00% | 0.00% |
| Sept. 2, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 1861 | $0.00 | 23,914.0000 | 71,004,640 | 8.44% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Ordinary Share | 2260 | $26.74 | 22,053.0000 | 71,004,640 | 9.30% | 0.00% |
| Sept. 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 4444 | $0.00 | 24,313.0000 | 71,004,640 | 22.37% | 0.01% |
| July 23, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Ordinary Share | 24248 | $24.79 | 19,253.0000 | 71,004,640 | 55.74% | 0.03% |
| July 23, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Ordinary Share | 24248 | $11.10 | 43,501.0000 | 71,004,640 | 125.94% | 0.03% |
| July 23, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 24248 | $0.00 | 40,412.0000 | 71,004,640 | 37.50% | 0.03% |
| April 26, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 509 | $17.88 | 19,253.0000 | 70,633,023 | 2.58% | 0.00% |
| April 26, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 991 | $0.00 | 990.0000 | 70,633,023 | 0.00% | 0.00% |
| April 26, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 991 | $0.00 | 19,762.0000 | 70,633,023 | 5.28% | 0.00% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 2694 | $0.00 | 19,562.0000 | 70,633,023 | 15.97% | 0.00% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Performance Share Unit | 5092 | $0.00 | 5,092.0000 | 70,633,023 | 9999.99% | 0.01% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 6365 | $0.00 | 11,615.0000 | 70,633,023 | 121.24% | 0.01% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 2694 | $0.00 | 8,921.0000 | 70,633,023 | 23.19% | 0.00% |
| April 8, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 791 | $17.90 | 18,771.0000 | 70,633,023 | 4.04% | 0.00% |
| April 4, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Share Option | 33150 | $0.00 | 33,150.0000 | 70,633,023 | 9999.99% | 0.05% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 514 | $19.70 | 16,868.0000 | 70,633,023 | 2.96% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1750 | $0.00 | 5,250.0000 | 70,633,023 | 25.00% | 0.00% |
| April 1, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 1750 | $0.00 | 17,382.0000 | 70,633,023 | 11.19% | 0.00% |
| Jan. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | S | Class A Common Share | 12000 | $20.00 | 15,632.0000 | 71,922,915 | 43.43% | 0.02% |
| Jan. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Share Option | 12000 | $0.00 | 0.0000 | 71,922,915 | 100.00% | 0.02% |
| Jan. 3, 2024 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 12000 | $8.83 | 27,632.0000 | 71,922,915 | 76.77% | 0.02% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 791 | $17.76 | 14,318.0000 | 71,634,729 | 5.24% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 1861 | $0.00 | 3,722.0000 | 71,634,729 | 33.33% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Share Option | 42050 | $0.00 | 42,050.0000 | 71,634,729 | 9999.99% | 0.06% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 7000 | $0.00 | 7,000.0000 | 71,634,729 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 2695 | $0.00 | 8,082.0000 | 71,634,729 | 25.01% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 547 | $17.76 | 15,632.0000 | 71,634,729 | 3.38% | 0.00% |
| Sept. 2, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 1861 | $0.00 | 16,179.0000 | 71,634,729 | 13.00% | 0.00% |
| Sept. 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 2695 | $0.00 | 15,109.0000 | 71,634,729 | 21.71% | 0.00% |
| April 26, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 990 | $0.00 | 12,705.0000 | 69,751,697 | 8.45% | 0.00% |
| April 26, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 291 | $11.15 | 12,414.0000 | 69,751,697 | 2.29% | 0.00% |
| April 26, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 990 | $0.00 | 1,981.0000 | 69,751,697 | 99.90% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 2695 | $0.00 | 8,082.0000 | 69,751,697 | 50.03% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 2695 | $0.00 | 12,506.0000 | 69,751,697 | 27.47% | 0.00% |
| April 10, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 791 | $10.71 | 11,715.0000 | 69,751,697 | 6.32% | 0.00% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Share Option | 42050 | $0.00 | 42,050.0000 | 69,751,697 | 9999.99% | 0.06% |
| April 1, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | A | Restricted Share Unit | 7000 | $0.00 | 7,000.0000 | 69,751,697 | 9999.99% | 0.01% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 872 | $0.00 | 1,744.0000 | 70,421,322 | 33.33% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 634 | $11.12 | 9,811.0000 | 70,421,322 | 6.07% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 2158 | $0.00 | 10,445.0000 | 70,421,322 | 26.04% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | F | Class A Common Share | 256 | $11.46 | 8,287.0000 | 70,421,322 | 3.00% | 0.00% |
| March 16, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Class A Common Share | 872 | $0.00 | 8,543.0000 | 70,421,322 | 11.37% | 0.00% |
| March 20, 2023 | Kiniksa Pharmaceuticals International, plc | $KNSA | Ragosa Mark | CHIEF FINANCIAL OFFICER | M | Restricted Share Unit | 2158 | $0.00 | 0.0000 | 70,421,322 | 100.00% | 0.00% |